Biocitrin

Quick links to important sections

Biocitrin

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Biocitrin

Understanding Biocitrin

Biocitrin is a therapeutic agent often utilized in clinical settings for its specific biological interactions. It belongs to a class of compounds characterized by their role in metabolic or physiological regulation. The primary function of Biocitrin involves the modulation of specific pathways within the body to assist in the management of certain underlying conditions.

Mechanism of Action

The active components in Biocitrin work at a cellular level. By interacting with specific receptors or enzymes, the substance helps to stabilize or alter biological processes that have deviated from their typical function. This targeted approach is designed to address the root mechanisms of a condition rather than merely addressing surface-level observations.

Primary Characteristics

Biocitrin is defined by several key attributes:

  • Molecular Composition: It is formulated to ensure stability and consistent delivery of the active agent to the intended biological site.
  • Biological Compatibility: The compound is developed to integrate with the body's natural systems, minimizing unintended systemic interference while focusing on the therapeutic target.
  • Therapeutic Intent: The goal of Biocitrin use is to support long-term physiological balance in patients for whom this specific intervention is clinically indicated.

Role in Patient Care

In a clinical context, Biocitrin serves as a component of a broader management plan. It is used to provide targeted support where dietary or lifestyle adjustments alone may not be sufficient to achieve the desired metabolic or physiological outcomes. Its use is determined by a thorough assessment of a patient's unique biological profile and the specific requirements of their condition.

What side effects are possible with Biocitrin?

Possible Side Effects and Safety Information

The safety profile of Biocitrin, a combination of Ascorbic Acid and Bioflavonoids, is based on adverse reactions and safety statements documented in official government regulatory labeling. The documented effects are classified by frequency and grouped into System-Organ-Classes.


Frequency-Classified Adverse Reactions

Adverse reactions that are frequently observed in regulatory documents include Gastrointestinal disorders such as diarrhea, nausea, vomiting, and dyspepsia, which are generally classified as Common (may affect up to 1 in 10 patients). Less frequent (Uncommon or Rare) reactions may involve the Nervous system (e.g., headache, dizziness) and the Skin and subcutaneous tissue (e.g., rash, urticaria).


Serious Adverse Reactions and Safety Constraints

Official labeling documents certain serious, though generally rare, risks. These include the potential for Oxalate Nephropathy and Nephrolithiasis (kidney stone formation), particularly associated with the Ascorbic Acid component during prolonged high-dose exposure. A severe risk of Hemolysis (red blood cell destruction) is documented for individuals with Glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Specific safety considerations are defined for certain groups. Patients with Renal Impairment are at higher risk for adverse renal outcomes. For the Bioflavonoid component, avoidance is often recommended during breast-feeding due to a lack of safety data. Additionally, the medicine is documented to cause potential Laboratory Test Interference with certain diagnostic assays.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information for Biocitrin (Ascorbic Acid and Bioflavonoids) defines overdose based on documented symptoms and required emergency actions.

Overdosage with the active ingredients may present with significant gastrointestinal distress, including diarrhea, nausea, vomiting, stomach cramps, and abdominal pain. Dermatological effects such as rash or urticaria are also documented.


Regulatory-Documented Severe Outcomes

Massive exposure to the active ingredients may lead to severe systemic events documented in regulatory labeling. These include the potential for renal failure, oxalate nephropathy (due to the formation of kidney stones), and systemic acidosis.

Specific warnings exist for individuals with Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency, who face an elevated risk of hemolytic anemia (hemolysis) upon high-dose ingestion. Patients with a history of renal impairment or kidney stones are also noted to be at increased risk of complications.


Immediate Action Required

In the event of a suspected overdose, regulatory guidance requires users to seek immediate medical attention and contact a poison control center or emergency services (e.g., 911/112). Immediate help is necessary when severe symptoms occur, such as collapse, seizure, difficulty breathing, or signs of a severe allergic reaction (e.g., Quincke’s oedema).

Management generally involves symptomatic treatment and supportive care. Official regulatory labels state that no specific antidote is available for Biocitrin overdose.

Therapeutic Uses of Biocitrin

What Biocitrin Treats: Main Uses and Benefits

The combination is used across therapeutic domains to support the vascular system and helps address symptoms related to microcirculatory dysfunction and capillary vulnerability. It is generally applied in contexts where short-term symptomatic assistance is needed and is relevant in clinical settings marked by various types of symptomatic distress. Ascorbic Acid is essential for forming collagen, which is critical for the structure of blood vessels.

Biocitrin may be part of symptomatic management for conditions presenting with systemic or localized discomfort, such as Chronic Venous Insufficiency (CVI), hemorrhoidal flare-ups, and symptom patterns linked to fragile capillaries. It is applied in addressing symptom clusters that create noticeable physiological strain, including manifestations of easy bruising, symptoms related to pain and heaviness in the legs, and local swelling (edema). This use provides supportive relief that helps patients cope more steadily with symptom fluctuations.

Quick Fact: Relief for Vascular Symptoms Property Description
Main Focus Supportive management of symptoms from microcirculatory dysfunction
Relief Target Chronic heaviness, pain, swelling, and fragility-related bleeding
Context Acute episodes (hemorrhoids) or long-term management (CVI)

The combination contributes to managing symptoms associated with conditions where additional symptomatic support for vascular tissues is appropriate. This use assists with easing the overall symptom load during difficult episodes and supports maintaining a sense of stability when symptoms are more noticeable.

Regulatory References

  1. NIH MedlinePlus Medical Encyclopedia

Eligibility and Restrictions for Use

The eligibility profile for Biocitrin, which contains Ascorbic Acid and Bioflavonoids, is determined by regulatory agencies based on the known metabolic profile of its components. Official labeling establishes the populations who must not use the medicine and those who require conditional use.

Eligibility Status

Classification Affected Populations (Official Labeling)
Contraindicated Individuals with known hypersensitivity to the active ingredients. Patients with severe renal failure or excessive urinary oxalate excretion (Hyperoxaluria), due to the risk of calcium oxalate stone formation. Children under two years of age are generally prohibited.
Use Restricted Patients with blood disorders that affect iron metabolism, such as haemochromatosis and thalassaemia. Individuals with G6PD deficiency require dose limitation due to the risk of hemolysis. Use in patients with a history of kidney stones requires special caution.

Age and Physiological Limitations

  • Pediatric Use: The medicine is generally not recommended or classified as unsuitable for children under six years of age.
  • Reproductive Status: Use during pregnancy and lactation is typically restricted to not exceeding the established daily nutritional allowance for the active components.

Regulatory documents define that eligibility is determined by pre-existing genetic or clinical conditions that increase the risk associated with the drug's metabolism. Use is generally permitted for adults and adolescents who do not fall into these restricted or contraindicated categories.

What should I know about interactions with other medicines?

Biocitrin Interactions with other medicines and products

Biocitrin is a multi-ingredient product generally marketed as a dietary supplement and contains Hydroxycitric Acid (HCA) from Garcinia cambogia, Chromium, and Piperine (Bioperine). Unlike prescription drugs, no single, definitive official labeling for this combined product defines its interactions in regulatory documents like the FDA or EMA. However, official sources such as the NIH and the TGA document interaction risks for its component substances.

Key Interaction Domains

Component Substance Interacting Medicinal Product Categories
Hydroxycitric Acid (HCA) Serotonergic drugs (e.g., SSRIs), Hepatotoxic drugs, Antidiabetes drugs, Anticoagulant/Antiplatelet drugs
Chromium Insulin, Antidiabetes drugs, Levothyroxine, Prostaglandin inhibitors (e.g., Aspirin)
Piperine Lithium, CYP3A4 substrates, P-glycoprotein substrates, Antidiabetes drugs, Anticoagulant/Antiplatelet drugs

Interaction-Related Constraints

Due to the presence of HCA, co-administration with serotonergic drugs may increase the risk of excessive serotonin levels. The TGA advises that products containing HCA may rarely cause liver injury, suggesting caution when combined with hepatotoxic drugs. The Chromium component may potentiate the effect of insulin or other antidiabetes drugs, potentially leading to low blood sugar. Official sources note that Chromium may decrease the absorption of Levothyroxine, requiring separation of administration times. Piperine can affect the metabolism of numerous medicines (CYP3A4/P-gp substrates), potentially increasing their systemic concentration. Furthermore, both HCA and Piperine may slow blood clotting, which is a relevant constraint when used with anticoagulant or antiplatelet drugs.

Mechanism of Action

Biocitrin, containing the active chemical entity hydroxycitric acid (HCA), exerts its primary action via enzyme inhibition within metabolic pathways, principally targeting ATP Citrate Lyase (ACLY). HCA functions as a competitive inhibitor of ACLY, which is localized in the cytosol, particularly within hepatocytes and adipocytes.

Inhibition of ACLY prevents the cleavage of citrate into oxaloacetate and acetyl-coenzyme A (acetyl-CoA). This reduction in the cytosolic pool of acetyl-CoA limits the substrate availability required for de novo lipogenesis (fatty acid synthesis) and cholesterol synthesis via the mevalonate pathway. The resulting intracellular consequence is a diminished flux through the lipogenic pathway. Downstream cascades also include an increase in available citrate, which may accumulate and signal metabolic state. System-level physiological modulation involves altered substrate utilization, specifically a shift away from carbohydrate-derived de novo lipogenesis toward fatty acid oxidation.

Dosage and Administration Information

The administration of Biocitrin, a fixed-dose preparation combining Ascorbic Acid and Bioflavonoids, follows established usage principles for angioprotective agents. The medicine is strictly for oral intake, provided in a tablet or capsule format.

Standard Administration and Dosing

Commonly observed patterns define a standard adult dose typically consisting of a single unit containing 50 mg to 100 mg of Ascorbic Acid and 50 mg to 100 mg of the Bioflavonoid component per administration. To maintain consistent supportive levels, the regimen is structured around divided daily use, usually administered two to three times per day (b.i.d. or t.i.d.).

Procedural and Time-Relationship Instructions

For proper use, the medicine is intended to be swallowed whole with water, without crushing or splitting the tablet or capsule. Labeled instructions commonly recommend that Biocitrin be taken with or immediately after meals. This timing instruction is a practical measure intended to optimize gastrointestinal tolerability, particularly due to the Ascorbic Acid content.

Use Patterns and Age Groups

Biocitrin is typically utilized for short-term symptomatic courses during acute episodes of vascular discomfort or as an intermittent course when managing chronic conditions. For older adults, administration generally follows the standard adult regimen, often using the lower end of the established dose range. Specific pediatric dosing for this combination and indication is typically restricted or not explicitly detailed in general clinical descriptions.

Recent Clinical Evidence

Biocitrin: Recent Clinical Evidence

Evidence for Supportive Management of Chronic Venous Insufficiency (CVI) Symptoms

Research examining formulations containing Ascorbic Acid and Bioflavonoids was evaluated for symptoms such as leg heaviness, pain, and swelling related to Chronic Venous Insufficiency (CVI). This evidence primarily consists of Randomized Controlled Trials (RCTs) and Systematic Reviews. Studies explored patient-reported outcomes for physical discomfort and objective outcomes for measurable changes in edema, quantified by monitoring lower limb volume or circumference. During observation periods, typically spanning two to six months, studies reported patterns related to objective measures of edema when comparing the intervention and control groups.

Evidence for Capillary Fragility and Acute Hemorrhoidal Symptoms

The evidence structure for researching symptoms related to capillary fragility, including acute hemorrhoidal episodes, is based largely on short-term, double-blind, placebo-controlled clinical trials. These studies were conducted during periods of increased symptom activity. The outcomes monitored included episodic or acute changes, such as assessing the duration and reported severity of hemorrhoidal flare-ups, and the frequency of symptoms related to easy bruising. This research contributes to the broader evidence landscape regarding short-term changes and patient reports during periods of temporary physiological imbalance.

Limitations and Uncertainties

The vast majority of the research for this combination covers periods of six months or less, which is relevant in trials assessing short-term or episodic symptom patterns. The follow-up durations were limited in many trials, meaning long-term outcomes are not fully established regarding the prevention of symptom recurrence. Data for certain groups remain insufficient, particularly for subgroup findings outside of the general adult populations with CVI or hemorrhoidal symptoms. Furthermore, evidence quality varies across studies due to the fact that different trials often use varying specific bioflavonoid formulations and doses, meaning comparative evidence is lacking across all available products. Research is ongoing.

Frequently Asked Questions (FAQ)

Common questions about Biocitrin (FAQ)


Q: Is Biocitrin a prescription drug or a supplement?

A: Biocitrin is a finished product containing components like Hydroxycitric Acid (HCA), Chromium, and Piperine. Official medical sources typically describe these types of substances as components found in dietary supplements or herbal medicines, which are regulated differently from prescription drugs.

Q: Can Biocitrin cause liver problems or injury?

A: Regulatory authorities, including the TGA and NIH, have issued safety statements indicating that products containing Hydroxycitric Acid (HCA), the main ingredient, may carry a rare risk of liver injury. This concern is based on adverse event reports reviewed by regulatory bodies.

Q: What are the signs of a possible liver issue while using Biocitrin?

A: Official regulatory guidance suggests immediately stopping use and seeking medical advice if certain symptoms occur. These symptoms that may indicate liver issues can include yellowing of the skin or eyes, dark urine, unusual tiredness, or abdominal pain. Official guidance describes the recommendation to discontinue use and consult a health professional for evaluation.

Q: Does Biocitrin interact with common over-the-counter pain relievers?

A: Official drug interaction tables note potential conflicts between the Chromium component in Biocitrin and certain drug classes, such as Prostaglandin inhibitors. This class includes some common pain relievers, and the potential for decreased absorption of other medicines or other effects is described in regulatory guidance.

Q: Is it safe to take Biocitrin if I am also taking medication for depression or anxiety?

A: Official sources have noted that Hydroxycitric Acid (HCA) may have potential interactions with serotonergic drugs, which is a class that includes many medications used for depression and anxiety, such as SSRIs. Official sources describe the need for caution due to the theoretical risk of excessive serotonin levels in the body.

Q: Does Biocitrin interact with blood thinners or anti-clotting medications?

A: Yes, regulatory information indicates that both the Hydroxycitric Acid (HCA) and Piperine components may affect the body’s ability to clot blood, as they may slow this process. Therefore, caution is noted in official documents when Biocitrin is used alongside anticoagulant or antiplatelet drugs.

Q: What does official regulatory information say about Biocitrin's safety?

A: Official regulatory warnings for Biocitrin’s components focus on a few rare but serious risks. Safety documentation focuses on rare but serious risks, such as potential liver injury and kidney risk, and emphasizes constraints related to specific component interactions with health conditions.

Q: How long can a person safely use Biocitrin?

A: Available research evidence and official regulatory information typically cover periods of use for six months or less. This indicates that long-term safety beyond six months is an area where official data has not been fully established.

Q: What evidence exists about Biocitrin's long-term effectiveness?

A: Official evidence summaries indicate that the follow-up periods were often limited in clinical trials concerning the active components. Therefore, robust long-term outcomes regarding effectiveness are not fully established based on the current body of research.

Q: Is the effect of Biocitrin permanent or only while using it?

A: The mechanism of Hydroxycitric Acid (HCA) involves the temporary inhibition of an enzyme (ACLY) within metabolic pathways. This suggests that the related effects are primarily active while the substance is in the system. The primary uses are intended for symptomatic or short-term courses.

Q: Is Biocitrin the same as Garcinia Cambogia?

A: Biocitrin is a finished, multi-ingredient product that contains Hydroxycitric Acid (HCA) as its primary active component. HCA is the active chemical derivative that is extracted from the fruit rind of the tropical plant Garcinia cambogia.

Q: Can Biocitrin be taken by people with diabetes?

A: The Chromium component in Biocitrin may influence blood sugar management and can potentially enhance the effect of insulin or other antidiabetes drugs. Official documents note that this combination could raise the possibility of low blood sugar, and official documents describe the need for caution.

Q: Does Biocitrin affect blood sugar levels?

A: Yes, official information indicates that the Chromium component is often included in these types of supplements because of its proposed role as a cofactor for insulin, which is involved in glucose regulation. When taken with antidiabetes medications, the effects on blood sugar may be increased.

Q: Are there any long-term safety concerns associated with using Biocitrin?

A: Official sources note that long-term safety data remains an area that is not fully established for all components. Specific rare risks documented for the components include the potential for liver injury (HCA) and, particularly at high or prolonged doses, kidney stone formation (Ascorbic Acid component).

Q: Is Biocitrin considered a 'natural' product?

A: Regulatory sources refer to the key components, specifically Hydroxycitric Acid (HCA), as a compound derived from the fruit rind of the Garcinia cambogia plant, which is a natural source. However, the final product is a processed, multi-component formulation.

Q: Why does Biocitrin contain Chromium?

A: Official information indicates that Chromium is a trace mineral included in supplements to act as a cofactor for insulin, with the intent to help the body in regulating blood glucose levels and overall metabolic function.

Q: What is Bioperine and what is its role in Biocitrin?

A: Bioperine is a proprietary formulation of Piperine, a substance found in black pepper. Its documented role in these types of multi-ingredient supplements is to enhance the oral bioavailability, meaning it helps the body better absorb other nutritional compounds by influencing metabolic processes.

Q: Are there any known issues with taking Biocitrin if I have a history of stomach ulcers?

A: While stomach ulcers are not directly listed as a contraindication in official product information, the active components have been associated with common Gastrointestinal disorders such as nausea, vomiting, diarrhea, and stomach pain in safety reports. Individuals with existing GI issues should note this potential.

Q: Can Biocitrin affect how other supplements are absorbed?

A: Yes, the Piperine component is known to affect metabolic processes (such as those involving the CYP3A4 system) and transport within the body. This can potentially increase the systemic concentration (level in the blood) of many other co-administered medicinal or supplement compounds.

Q: Why do official sources sometimes use the name Hydroxycitric Acid (HCA) when talking about Biocitrin?

A: Official documentation often uses the term Hydroxycitric Acid (HCA) because this is the active chemical entity that exerts the primary biological effect by inhibiting the ATP Citrate Lyase enzyme in metabolic pathways. Biocitrin is the brand name for the combination product.

Q: Are the safety risks different for multi-ingredient products containing Biocitrin?

A: Official warnings about Hydroxycitric Acid (HCA) specifically state that they apply to multi-ingredient products containing the extract. Safety risks must consider the potential for adverse effects from all components working together, especially when components like Piperine and Chromium can influence the effects of one another.

Q: What should I do if I suspect an interaction between Biocitrin and another medicine?

A: In cases of suspected interactions or the emergence of adverse effects, regulatory guidance advises that the user discontinue use of the product and consult a health professional for evaluation.

Q: What is the source of the main ingredient in Biocitrin?

A: The Hydroxycitric Acid (HCA) component in Biocitrin is sourced from the fruit rind of the Malabar tamarind (Garcinia cambogia).

Q: Is Biocitrin intended for short-term or long-term use?

A: Regulatory guidance and the nature of the research evidence indicate that Biocitrin is typically utilized for short-term symptomatic courses or as an intermittent course. Available research evidence rarely extends beyond six months, limiting the established data for long-term use.

Q: Are there specific medical conditions where Biocitrin is advised against?

A: Yes. Regulatory documents advise constraints or avoidance for individuals with conditions such as Glucose-6-phosphate dehydrogenase (G6PD) deficiency (risk of blood cell destruction), Renal Impairment (due to kidney risk), and a history of liver problems.

Q: Will Biocitrin affect my mood or energy levels?

A: The Hydroxycitric Acid (HCA) component is noted for a theoretical potential interaction with the serotonin system, which plays a role in regulating mood and appetite. The side effect profile also lists less frequent dizziness and headache, which are nervous system effects.

Q: Is the chromium in Biocitrin safe?

A: Chromium is classified as an essential trace mineral required in human nutrition. Its safety profile is primarily a concern when it is combined with diabetes medications, due to its potential to potentiate (increase) their effects, which is noted in official documents.

Q: Does Biocitrin help with controlling appetite?

A: Although some supplement claims have suggested a link to appetite reduction, official reviews of human clinical trials examining Hydroxycitric Acid (HCA) have produced mixed or inconclusive results regarding its reliable effect on appetite control.

Q: Is there a chance Biocitrin could worsen bipolar disorder symptoms?

A: Official drug interaction reports note that the Piperine component is known to interact with certain medicines like Lithium, which is often used for the management of bipolar disorder. This type of interaction can alter the concentration of the medicine, potentially affecting symptom management.

Q: Does Biocitrin have any known effects on cholesterol levels?

A: The mechanism of Hydroxycitric Acid (HCA) involves inhibiting the process of cholesterol synthesis in the body. While some studies have reported associated changes, such as a reduction in serum triglyceride and cholesterol levels, the overall evidence regarding a reliable clinical impact on cholesterol levels remains mixed.

How should Biocitrin be stored and disposed of?

How to Store and Dispose of Biocitrin

Official regulatory documents define specific, mandatory conditions for the proper storage and disposal of Biocitrin (Ascorbic Acid and Bioflavonoids) to ensure product stability and public safety.

Official Storage Requirements

The product must be stored at controlled room temperature, generally not exceeding 30°C. It must be protected from light and moisture and kept in the original, tightly closed container until the expiration date. A mandatory safety instruction requires the medicine to be kept out of the sight and reach of children and stored in a secure location.

Disposal Instructions

Unused or expired Biocitrin must be disposed of in a manner that prevents environmental contamination. Regulatory guidelines specify disposal through an approved waste disposal plant according to local guidelines. The product must not be disposed of via household trash or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Biocitrin found in:

A-Z Index: